Cannabis company Tilray Brands (NASDAQ: TLRY) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 4.7% year on year to $209.5 million. Its non-GAAP loss of $0 per share increased from -$0.04 in the same quarter last year.

Is now the time to buy TLRY? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Tilray’s third quarter results were met with a strong positive response from the market, reflecting the company's progress in expanding its diversified business model and achieving a notable improvement in operating margin. Management attributed the quarter’s performance to double-digit growth in Canadian adult-use and international cannabis segments, as well as operational improvements across its beverage and wellness divisions. CEO Irwin Simon highlighted that, outside of a flat beverage segment affected by SKU rationalization, all core business lines contributed to revenue growth, with focused efforts on product innovation and efficiency driving the company’s improved profitability.

Looking ahead, Tilray’s management emphasized a strategy centered on capturing emerging opportunities in both the global cannabis market and adjacent categories such as hemp-derived beverages and wellness products. CEO Irwin Simon pointed to ongoing regulatory developments, particularly in the U.S. and Europe, as key potential accelerators for future growth. The company aims to leverage its large-scale production capabilities, expanded distribution reach, and new product launches, with Simon stating, “We are committed to unlocking new possibilities through continuous innovation, portfolio expansion, and targeted investments, including the opportunities when strategic acquisitions happen.”

Key Insights from Management’s Remarks

Management credited third quarter momentum to international cannabis expansion, operational streamlining in beverages, and targeted innovation in wellness and hemp-based products.

• International cannabis expansion: Tilray’s international cannabis segment grew 10%, driven by increased production capacity in Portugal and Germany, and improved distribution through CC Pharma’s network in Germany. Management highlighted regulatory progress and new licenses in Italy and Spain as catalysts for market entry and expansion.
• Canadian market share leadership: The company reinforced its top position in Canada’s legal cannabis market, with volume growth outpacing the broader market and price increases achieved despite sector-wide pricing pressure. Tilray managed to gain share in key product categories such as pre-rolls, beverages, and edibles.
• Beverage operational improvements: Project 420 continued to streamline the beverage portfolio, including SKU rationalization and facility integration. Management noted cost savings and a turnaround in acquired brands like Shock Top, which saw significant sales growth after relisting in key retailers.
• Wellness product innovation: The wellness business grew through new launches in high-protein hemp snacks and energy drinks, expanding retail presence to over 17,000 locations and strengthening partnerships with major chains and online platforms such as Whole Foods and Amazon.
• Balance sheet strengthening: Tilray reduced outstanding debt and improved its net debt-to-EBITDA ratio, while selectively raising capital through its at-the-market (ATM) program. Management cited these actions as providing flexibility to pursue acquisitions and withstand industry volatility.

Drivers of Future Performance

Tilray’s guidance centers on expanded international cannabis access, new product launches, and the evolving regulatory landscape as key drivers of future results.

• Regulatory changes and market access: Management believes that ongoing regulatory reforms in Europe and potential U.S. cannabis rescheduling could open sizable new markets, particularly for medical cannabis. CEO Irwin Simon noted the company is positioned to scale quickly should access improve, with established infrastructure in Canada, Portugal, and Germany.
• Portfolio and distribution expansion: Tilray is investing in new products—including hemp-derived Delta-9 THC beverages and energy drinks—and growing its distribution footprint, especially in international markets. Recent partnerships and a dedicated team for international beverage expansion are expected to drive incremental growth.
• Operational efficiency and margin recovery: The company continues to rationalize its beverage portfolio and optimize supply chains, aiming to improve margins that were temporarily compressed by product mix changes. Management highlighted ongoing cost savings and integration of acquired brands as essential to restoring profitability in challenged categories.

Catalysts in Upcoming Quarters

In future quarters, the StockStory team will be watching (1) the pace of regulatory changes in key markets like Germany and the U.S., (2) the impact of new product introductions—especially in hemp-based beverages and wellness—on overall revenue mix, and (3) ongoing gains in operational efficiency and margin recovery in the beverage segment. Progress on international distribution expansion will also be a critical marker.

Tilray currently trades at $1.99, up from $1.73 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free for active Edge members).

Now Could Be The Perfect Time To Invest In These Stocks

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.